Mercator Medical S.A.
WSE:MRC.WA
41.48 (PLN) • At close December 14, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) PLN.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 469.064 | 542.512 | 1,727.349 | 1,834.174 | 540.333 | 420.41 | 300.764 | 263.591 | 226.593 | 168.482 | 147.811 | 132.171 |
| Cost of Revenue
| 378.18 | 454.213 | 1,043.547 | 644.271 | 427.65 | 322.792 | 238.901 | 197.307 | 168.321 | 124.722 | 111.283 | 101.713 |
| Gross Profit
| 90.884 | 88.299 | 683.802 | 1,189.903 | 112.683 | 97.618 | 61.863 | 66.284 | 58.272 | 43.76 | 36.528 | 30.458 |
| Gross Profit Ratio
| 0.194 | 0.163 | 0.396 | 0.649 | 0.209 | 0.232 | 0.206 | 0.251 | 0.257 | 0.26 | 0.247 | 0.23 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 61.937 | 61.628 | 38.479 | 25.904 | 19.733 | 14.224 | 11.304 | 11.075 | 9.819 | 8.156 | 7.706 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 126.697 | 61.937 | 61.628 | 38.479 | 25.904 | 19.733 | 14.224 | 11.304 | 11.075 | 9.819 | 8.156 | 7.706 |
| Other Expenses
| 51.464 | 99.766 | 107.292 | 100.181 | 79.379 | 61.389 | -0.641 | -0.127 | -1.592 | 0 | 0 | 0 |
| Operating Expenses
| 154.819 | 161.703 | 168.92 | 138.66 | 105.283 | 81.122 | 55.705 | 47.767 | 41.857 | 30.746 | 24.355 | 22.392 |
| Operating Income
| -87.115 | -73.404 | 463.433 | 1,047.621 | 10.148 | 16.414 | 8.547 | 18.23 | 16.493 | 13.112 | 11.556 | 8.546 |
| Operating Income Ratio
| -0.186 | -0.135 | 0.268 | 0.571 | 0.019 | 0.039 | 0.028 | 0.069 | 0.073 | 0.078 | 0.078 | 0.065 |
| Total Other Income Expenses Net
| 83.323 | -5 | 13.792 | -7.055 | -5.124 | -8.283 | -2.561 | -1.207 | -5.889 | -1.186 | -3.028 | -1.124 |
| Income Before Tax
| -3.792 | -186.215 | 477.225 | 1,040.566 | 2.069 | 8.131 | 5.986 | 17.023 | 10.604 | 11.926 | 8.528 | 7.422 |
| Income Before Tax Ratio
| -0.008 | -0.343 | 0.276 | 0.567 | 0.004 | 0.019 | 0.02 | 0.065 | 0.047 | 0.071 | 0.058 | 0.056 |
| Income Tax Expense
| 19.044 | 4.571 | 32.373 | 104.997 | 4.1 | 1.086 | 0.622 | 2.182 | 0.297 | 1.907 | 1.619 | -1.011 |
| Net Income
| -19.676 | -190.786 | 446.865 | 930.185 | -2.031 | 7.468 | 4.927 | 13.904 | 10.272 | 10.019 | 6.868 | 7.759 |
| Net Income Ratio
| -0.042 | -0.352 | 0.259 | 0.507 | -0.004 | 0.018 | 0.016 | 0.053 | 0.045 | 0.059 | 0.046 | 0.059 |
| EPS
| -2.05 | -19.53 | 44.15 | 88.66 | -0.19 | 0.71 | 0.47 | 1.5 | 1.19 | 1.16 | 0.79 | 0.9 |
| EPS Diluted
| -2.05 | -19.53 | 44.15 | 88.33 | -0.19 | 0.71 | 0.47 | 1.5 | 1.18 | 1.16 | 0.79 | 0.9 |
| EBITDA
| 19.427 | -159.746 | 497.076 | 1,063.969 | 28.104 | 28.265 | 17.019 | 26.978 | 18.888 | 16.751 | 14.366 | 11.93 |
| EBITDA Ratio
| 0.041 | -0.294 | 0.288 | 0.58 | 0.052 | 0.067 | 0.057 | 0.102 | 0.083 | 0.099 | 0.097 | 0.09 |